\-\ Texto\\:\\ \ \(0\)\
\-\ on\\ physical\\ exam\\,\\ patient\\ is\\ visibly\\ uncomfortable\\,\\ moderately\\ jaundiced\\,\\ with\\ abdominal\\ distention\\ and\\ mild\\ tenderness\\ to\\ palpation\\ of\\ ruq\\.\ \(0\)\
\-\ labs\\ reveal\\ transaminitis\\.\ \(0\)\
\-\ \\â\\€\\¢immediately\\ following\\ imaging\\,\\ a\\ biliary\\ stent\\ was\\ placed\\.\\ 3\\ courses\\ of\\ chemotherapy\\ with\\ agressive\\ tumor\\ lysis\\ syndrome\\ prophylaxis\\ were\\ given\\ and\\ tolerated\\.\\ \ \(0\)\
\-\ \\â\\€\\¢recent\\ pet\\ study\\ obtained\\ showed\\ no\\ evidence\\ of\\ disease\\ recurrence\\.\ \(0\)\
\-\ \\â\\€\\¢ruq\\ ultrasound\\:\\ a\\ heterogenous\\ mass\\ in\\ the\\ region\\ of\\ the\\ head\\ of\\ the\\ pancreas\\ with\\ hepatic\\ biliary\\ ductal\\ dilation\\.\ \(0\)\
\-\ \\â\\€\\¢ct\\ chest\\/abd\\/pelvis\\ w\\/contrast\\:\\ multiple\\ ground\\ glass\\ opacities\\ bilaterally\\ in\\ lungs\\,\\ large\\ mass\\ about\\ the\\ pancreatic\\ head\\ which\\ surrounds\\ the\\ periaortic\\ tissues\\ and\\ celiac\\ axis\\.\ \(0\)\
\-\ \\â\\€\\¢pet\\ scan\\:\\ focal\\ increased\\ uptake\\ about\\ the\\ pancreatic\\ head\\,\\ scattered\\ foci\\ bilateral\\ lungs\\ l\\>r\ \(0\)\
\-\ burkitt\\'s\\ lymphoma\ \(0\)\
\-\ \\â\\€\\¢pancreatitis\ \(1\)\
\-\ \\â\\€\\¢pancreatic\\ cancer\ \(1\)\
\-\ \\â\\€\\¢lymphoma\ \(1\)\
\-\ \\â\\€\\¢soft\\ tissue\\ sarcoma\ \(1\)\
\-\ \\â\\€\\¢metastatic\\ disease\ \(2\)\
\-\ 46\\ year\\ old\\ male\\ presented\\ to\\ gastroenterology\\ clinic\\ complaining\\ of\\ 2\\ weeks\\ of\\ abdominal\\ fullness\\,\\ early\\ satiety\\,\\ pale\\ colored\\ stools\\.\\ admits\\ two\\ days\\ of\\ nausea\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\â\\€\\¢immediately\\:\\ 0\\.05185599072921469\ \(0\)\
\-\ \\â\\€\\¢ruq\\:\\ 0\\.05185599072921469\ \(0\)\
\-\ \\â\\€\\¢pet\\:\\ 0\\.05185599072921469\ \(0\)\
\-\ \\â\\€\\¢pancreatitis\\:\\ 0\\.05185599072921469\ \(0\)\
\-\ \\â\\€\\¢pancreatic\\:\\ 0\\.05185599072921469\ \(0\)\
\-\ biliary\\:\\ 0\\.05077304416042627\ \(0\)\
\-\ pancreatic\\:\\ 0\\.0491857580674925\ \(0\)\
\-\ \\â\\€\\¢recent\\:\\ 0\\.04777865437297972\ \(0\)\
\-\ transaminitis\\:\\ 0\\.045393565501755224\ \(0\)\
\-\ \\â\\€\\¢soft\\:\\ 0\\.045393565501755224\ \(0\)\
\-\ chest\\/abd\\/pelvis\\:\\ 0\\.04370131801674475\ \(0\)\
\-\ head\\:\\ 0\\.042769434892480515\ \(0\)\
\-\ visibly\\:\\ 0\\.04238870889136705\ \(0\)\
\-\ agressive\\:\\ 0\\.04238870889136705\ \(0\)\
\-\ \\â\\€\\¢ct\\:\\ 0\\.04131622914552025\ \(0\)\
\-\ \\â\\€\\¢lymphoma\\:\\ 0\\.04131622914552025\ \(0\)\
\-\ \\â\\€\\¢metastatic\\:\\ 0\\.04131622914552025\ \(0\)\
\-\ uncomfortable\\:\\ 0\\.04040946044065403\ \(0\)\
\-\ colored\\:\\ 0\\.04040946044065403\ \(0\)\
\-\ periaortic\\:\\ 0\\.039623981660509774\ \(0\)\
\-\ jaundiced\\:\\ 0\\.038931140274295756\ \(0\)\
\-\ w\\/contrast\\:\\ 0\\.038931140274295756\ \(0\)\
\-\ about\\:\\ 0\\.03875361771887355\ \(0\)\
\-\ burkitt\\:\\ 0\\.038311372535132074\ \(0\)\
\-\ gastroenterology\\:\\ 0\\.038311372535132074\ \(0\)\
\-\ lungs\\:\\ 0\\.03806810115270913\ \(0\)\
\-\ admits\\:\\ 0\\.03723889278928528\ \(0\)\
\-\ lysis\\:\\ 0\\.036768053332382124\ \(0\)\
\-\ satiety\\:\\ 0\\.036332124084419055\ \(0\)\
\-\ courses\\:\\ 0\\.03341190710610205\ \(0\)\
\-\ surrounds\\:\\ 0\\.03341190710610205\ \(0\)\
\-\ pale\\:\\ 0\\.03341190710610205\ \(0\)\
\-\ stools\\:\\ 0\\.03341190710610205\ \(0\)\
\-\ tolerated\\:\\ 0\\.03165606599694913\ \(0\)\
\-\ prophylaxis\\:\\ 0\\.03146930894803983\ \(0\)\
\-\ celiac\\:\\ 0\\.03094217860280638\ \(0\)\
\-\ glass\\:\\ 0\\.02908422007681534\ \(0\)\
\-\ moderately\\:\\ 0\\.028727604654365718\ \(0\)\
\-\ fullness\\:\\ 0\\.028727604654365718\ \(0\)\
\-\ ruq\\:\\ 0\\.028283442580788395\ \(0\)\
\-\ stent\\:\\ 0\\.028283442580788395\ \(0\)\
\-\ ground\\:\\ 0\\.027674379763489333\ \(0\)\
\-\ distention\\:\\ 0\\.026864842246571406\ \(0\)\
\-\ axis\\:\\ 0\\.026781403217206956\ \(0\)\
\-\ 46\\:\\ 0\\.026617994016577103\ \(0\)\
\-\ pet\\:\\ 0\\.026381088727530394\ \(0\)\
\-\ opacities\\:\\ 0\\.026228291748687686\ \(0\)\
\-\ heterogenous\\:\\ 0\\.02579236250072461\ \(0\)\
\-\ pancreas\\:\\ 0\\.025722748043977537\ \(0\)\
\-\ abdominal\\:\\ 0\\.025128461624966063\ \(0\)\
\-\ complaining\\:\\ 0\\.024536044263677212\ \(0\)\
\-\ ductal\\:\\ 0\\.023694274595202663\ \(0\)\
\-\ dilation\\:\\ 0\\.023694274595202663\ \(0\)\
\-\ scattered\\:\\ 0\\.023407273629500118\ \(0\)\
\-\ l\\:\\ 0\\.02291492645963749\ \(0\)\
\-\ r\\:\\ 0\\.02282967347550474\ \(0\)\
\-\ clinic\\:\\ 0\\.022460624412955196\ \(0\)\
\-\ reveal\\:\\ 0\\.022381665469824955\ \(0\)\
\-\ sarcoma\\:\\ 0\\.022381665469824955\ \(0\)\
\-\ recurrence\\:\\ 0\\.02192895346314185\ \(0\)\
\-\ foci\\:\\ 0\\.021576611453841443\ \(0\)\
\-\ hepatic\\:\\ 0\\.020991143245917717\ \(0\)\
\-\ tissues\\:\\ 0\\.020630886626854666\ \(0\)\
\-\ placed\\:\\ 0\\.02034665970173227\ \(0\)\
\-\ nausea\\:\\ 0\\.02023670597813137\ \(0\)\
\-\ uptake\\:\\ 0\\.019970490733495366\ \(0\)\
\-\ \\:\\:\\ 0\\.019946026164541147\ \(0\)\
\-\ early\\:\\ 0\\.018383288056720223\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.01801732814788744\ \(0\)\
\-\ obtained\\:\\ 0\\.017869800592610834\ \(0\)\
\-\ labs\\:\\ 0\\.01748220004079493\ \(0\)\
\-\ given\\:\\ 0\\.01723184936774319\ \(0\)\
\-\ palpation\\:\\ 0\\.016776112237341483\ \(0\)\
\-\ \\>\\:\\ 0\\.01670098538040332\ \(0\)\
\-\ study\\:\\ 0\\.016539007981529172\ \(0\)\
\-\ cancer\\:\\ 0\\.016524501555086855\ \(0\)\
\-\ bilaterally\\:\\ 0\\.01651003081484649\ \(0\)\
\-\ showed\\:\\ 0\\.016481195693668804\ \(0\)\
\-\ disease\\:\\ 0\\.016432206367243577\ \(0\)\
\-\ days\\:\\ 0\\.015406319389246926\ \(0\)\
\-\ tenderness\\:\\ 0\\.015287719546362549\ \(0\)\
\-\ ultrasound\\:\\ 0\\.014912485794154724\ \(0\)\
\-\ two\\:\\ 0\\.014396066103623562\ \(0\)\
\-\ syndrome\\:\\ 0\\.014375921039615538\ \(0\)\
\-\ lymphoma\\:\\ 0\\.014365874319938151\ \(0\)\
\-\ focal\\:\\ 0\\.014355844730225893\ \(0\)\
\-\ following\\:\\ 0\\.014266339746477343\ \(0\)\
\-\ weeks\\:\\ 0\\.014266339746477343\ \(0\)\
\-\ region\\:\\ 0\\.01419765427787831\ \(0\)\
\-\ scan\\:\\ 0\\.014072185061370462\ \(0\)\
\-\ mass\\:\\ 0\\.013981894199383112\ \(0\)\
\-\ presented\\:\\ 0\\.013702103735425936\ \(0\)\
\-\ mild\\:\\ 0\\.013236785023124335\ \(0\)\
\-\ evidence\\:\\ 0\\.013179074019805163\ \(0\)\
\-\ \\,\\:\\ 0\\.012739297200813524\ \(0\)\
\-\ physical\\:\\ 0\\.012332383938713167\ \(0\)\
\-\ increased\\:\\ 0\\.012296969304703857\ \(0\)\
\-\ bilateral\\:\\ 0\\.01219892781949673\ \(0\)\
\-\ tissue\\:\\ 0\\.011914242285015256\ \(0\)\
\-\ imaging\\:\\ 0\\.01177690484973884\ \(0\)\
\-\ 3\\:\\ 0\\.01177044427474435\ \(0\)\
\-\ tumor\\:\\ 0\\.011719013538887125\ \(0\)\
\-\ were\\:\\ 0\\.011413449039352477\ \(0\)\
\-\ \\'s\\:\\ 0\\.011082627166864971\ \(0\)\
\-\ exam\\:\\ 0\\.011042552587938459\ \(0\)\
\-\ large\\:\\ 0\\.010991426069594586\ \(0\)\
\-\ 2\\:\\ 0\\.010824144097120859\ \(0\)\
\-\ multiple\\:\\ 0\\.010587094138113345\ \(0\)\
\-\ which\\:\\ 0\\.009383203454367934\ \(0\)\
\-\ male\\:\\ 0\\.009089444340514547\ \(0\)\
\-\ was\\:\\ 0\\.005813397189492276\ \(0\)\
\-\ year\\:\\ 0\\.005624148642781851\ \(0\)\
\-\ of\\:\\ 0\\.005482531802258279\ \(0\)\
\-\ old\\:\\ 0\\.005146674099189733\ \(0\)\
\-\ no\\:\\ 0\\.0050614361806106\ \(0\)\
\-\ patient\\:\\ 0\\.005038776064214046\ \(0\)\
\-\ to\\:\\ 0\\.005024330687564544\ \(0\)\
\-\ in\\:\\ 0\\.0049576144722382936\ \(0\)\
\-\ the\\:\\ 0\\.004879386518951498\ \(0\)\
\-\ a\\:\\ 0\\.004665880021395309\ \(0\)\
\-\ on\\:\\ 0\\.004258182425678989\ \(0\)\
\-\ is\\:\\ 0\\.0033075928140277977\ \(0\)\
\-\ and\\:\\ 0\\.003176629512921502\ \(0\)\
\-\ with\\:\\ 0\\.0020647795780568776\ \(0\)\
\-\ \\.\\:\\ 0\\.0018793872051536262\ \(0\)\
